NCT00256698 · MORE INFO

Limitations, agreements, and source contact

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy · Source last updated 2012-08-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

other Details: The only disclosure restriction on the PI is that they cannot disclose or publish any information to do with the trial without consent from AstraZeneca
pi Sponsor Employee: false
restriction Type: OTHER
restrictive Agreement: true

point Of Contact

Complete source fields

certain Agreement

other Details: The only disclosure restriction on the PI is that they cannot disclose or publish any information to do with the trial without consent from AstraZeneca
pi Sponsor Employee: false
restriction Type: OTHER
restrictive Agreement: true

point Of Contact

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice